Gastric Neuroendocrine Carcinoma

specific

An aggressive high-grade carcinoma with neuroendocrine differentiation that arises from the stomach. It is composed of malignant small or large cells. The mitotic count is more than 20 per 2 mm2 and/or the Ki-67 index is more than 20%.

65

Centers

100

Active Trials

Cancer Funding

Top Centers for Gastric Neuroendocrine Carcinoma(65)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
Active Research Program
61.2
2
NCI Comprehensive
Active Research Program
61.2
3
NCI Comprehensive
Active Research Program
61.2
4
NCI Comprehensive
Active Research Program
61.2
5
NCI Comprehensive
Active Research Program
61.2
6
NCI Comprehensive
Active Research Program
61.2
7
NCI Comprehensive
Active Research Program
61.2
861.2
9
NCI Comprehensive
Active Research Program
61.2
10
NCI Comprehensive
Active Research Program
61.2
11
NCI Comprehensive
Active Research Program
61.2
12
NCI Comprehensive
Active Research Program
61.2
13
NCI Comprehensive
Active Research Program
61.2
14
NCI Comprehensive
Active Research Program
61.2
15
NCI Clinical
Active Research Program
61.2
16
NCI Comprehensive
Active Research Program
61.2
17
Active Research Program
61.2
18
Cedars-Sinai CancerLos Angeles, CA
Active Research Program
61.2
19
Active Research Program
61.2
20
NCI Clinical
Active Research Program
61.2
21
NCI Comprehensive
Active Research Program
61.2
22
NCI Comprehensive
Active Research Program
61.2
23
NCI Comprehensive
Active Research Program
61.2
24
Active Research Program
61.2
25
NCI Clinical
Active Research Program
61.2
26
NCI Comprehensive
Active Research Program
61.2
27
Active Research Program
61.2
2861.2
29
Active Research Program
61.2
30
Active Research Program
61.2
31
NCI Basic_laboratory
Active Research Program
61.2
32
Active Research Program
61.2
33
Active Research Program
61.2
34
Active Research Program
61.2
35
Active Research Program
61.2
36
NCI Comprehensive
Active Research Program
38.7
37
NCI Comprehensive
Active Research Program
38.7
38
NCI Comprehensive
Active Research Program
38.7
39
NCI Comprehensive
Active Research Program
38.7
40
NCI Comprehensive
Active Research Program
38.7
41
NCI Comprehensive
Active Research Program
38.7
42
NCI Comprehensive
Active Research Program
38.7
43
NCI Comprehensive
Active Research Program
38.7
44
NCI Comprehensive
Active Research Program
38.7
45
NCI Comprehensive
Active Research Program
38.7
46
NCI Comprehensive
Active Research Program
38.7
47
NCI Comprehensive
Active Research Program
38.7
48
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
Active Research Program
38.7
49
NCI Comprehensive
Active Research Program
38.7
50
NCI Comprehensive
Active Research Program
38.7
51
NCI Comprehensive
Active Research Program
38.7
52
NCI Clinical
Active Research Program
38.7
53
NCI Comprehensive
Active Research Program
38.7
54
NCI Comprehensive
Active Research Program
38.7
55
NCI Comprehensive
Active Research Program
38.7
56
NCI Comprehensive
Active Research Program
38.7
57
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive
Active Research Program
38.7
58
Active Research Program
38.7
59
NCI Comprehensive
Active Research Program
38.7
60
Active Research Program
38.7
61
Active Research Program
38.7
62
Active Research Program
38.7
63
Active Research Program
38.7
64
Active Research Program
38.7
65
Active Research Program
38.7

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →